Article

Eye, Skin, Bowel Signs Predate AS Diagnosis

Uveitis, irritable bowel syndrome, and psoriasis often turn up first in patients later diagnosed with ankylosing spondylitis, a large UK study shows.

Carmen Stolwijk C, Ivette Essers I, van Tubergen A, et al., The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study. Ann Rheum Dis  (2014) doi:10.1136/annrheumdis-2014-205253

Three key clues signal possible ankylosing spondylitis (AS) in patients with inflammatory back pain, a large population study suggests. These are:

•  acute anterior uveitis (AAU),
•  psoriasis, and
•  inflammatory bowel disease (IBD).

These extra-articular manifestations of AS, particularly uveitis, are often present before AS diagnosis. In this study, 11.4% of AS patients had AAU at first diagnosis.

The study compared 4,101 AS patients with 28,591 controls from the Clinical Practice Research Datalink (CPRD), a large UK medical records database, from 1989-2012. The AS patients showed a 16-fold increase in AAU prevalence.

Risks for psoriasis and IBD were lower compared to controls, at 150% and 330%, respectively. Also, fewer patients had these conditions at  diagnosis of AS (4.4% had psoriasis and 3.7% had IBD). \

The prevalence of extra-articular manifestations roughly doubled within 20 years of diagnosis, to 25% for AAU, 10% for psoriasis, and 7.5% for IBD.

Uveitis is especially common in axial or peripheral spondyloarthritis (SpA) but rare in the general population, making is an important red signal in patients with chronic low back pain, the researchers note. Psoriasis and IBD should also raise suspicion for SpA.

 

 

 

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.